Following the identification of B.1.1.529 variant, indicated by the WHO as Variant of Concern (VOC) on November 26, 2021 and designated as Omicron variant,
AB ANALITICA confirms that REALQUALITY RQ-2019-nCoV (RQ-129), REALQUALITY RQ-SARS-CoV-2 (RQ-130), REALQUALITY ABFlu-CoV-2 (RQ-131) and REALQUALITY ResP-Aria (RQ-133) kits, detect the Omicron variant as well as all variants of the SARS-CoV-2 virus.
Identified in early November 2021 in South Africa, the new variant of SARS-CoV-2 is characterized by several mutations in the S gene encoding the Spike protein. Preliminary evidence suggests an increased risk of infection with this variant compared to other VOCs. The number of cases of this variant appears to be increasing in almost all provinces of South Africa.
AB ANALITICA constantly checks the sequence databases such as GISAID and NCBI in order to ensure optimal performance of the products for SARS-CoV-2 identification. Sequence analysis shows that none of the mutations found in B.1.1.529 interfere with the kits of the covid line: REALQUALITY RQ-2019-nCoV (RQ-129), REALQUALITY RQ-SARS-CoV-2 (RQ-130), REALQUALITY ABFlu-CoV-2 (RQ-131) and REALQUALITY ResP-Aria (RQ-133)
Please, for more information contact: email@example.com